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Ymajor bleeding and eptiﬁbatide was modeled into the National Cardiovascular
Database Registry (NCDR) bleeding risk score to evaluate independent risk.
Results: Signiﬁcant procedure related differences exist between groups (Table 1),
while in hospital adverse events were similar (OR: 0.12; 95% CI, 0.90 - 2.96). No
difference in TIMI major bleeding was seen (3.9% vs. 6%; p ¼ 0.20). Eptiﬁbatide
modestly increased the bleeding risk (OR: 1.64; 95% CI, 1.01 - 2.67, p ¼ 0.045),
however, it did not improve the NCDR bleeding risk models’ ability to predict
events.
Conclusion: Use of combination therapy reﬂects a high risk STEMI population.
Despite this, the risk of in-hospital adverse events was not different between patients
receiving bivalirudin plus eptiﬁbatide vs. bivalirudin monotherapy. Likewise, combi-
nation therapy did not increase rates of major bleeding. Therefore, the use of eptiﬁ-
batide should be considered in the higher risk STEMI population.CRT-115
In the Current Era of ST Elevation Myocardial Infarction Treatment, What Patients Are
Not Reperfused? - An Observational Analysis
Laurna McGovern,1 Thomas J. Kiernan2
1University College Cork, Cork, Ireland; 2Limerick University Hospital, Limerick, Ireland
Background: The current treatment of ST segment elevation myocardial infarction
(STEMI) is mechanical reperfusion by Primary Percutaneous Coronary Intervention
(PPCI) or systemic thrombolysis. Several factors are related to non-reperfusion, with
advanced age being particularly signiﬁcant. At present, no study has examined the
presentation and characteristics of the non-reperfused patient in Ireland. Further study
is clearly needed in this area, especially as the older demographic of the population
increases.
Objective: To deﬁne, understand and critically evaluate STEMI patients who do not
receive reperfusion therapy.
Methods: The Coronary Heart Attack Ireland Register (CHAIR) was used to
identify STEMI patients who did not receive reperfusion therapy between January 1st
2007 and December 31st 2011. A retrospective review of patient charts was performed
at Cork University Hospital, Mercy University Hospital, South Inﬁrmary Victoria
University Hospital and Mallow General Hospital. The contribution of non-reper-
fusion to patient mortality was also examined in terms of 30-day mortality and 1-year
mortality post STEMI.
Results: 77 cases were included. Results indicate that most were female (n¼47, 61%)
with a median age of 80.39 years. 54.5% (n¼42) had a past medical history of coronary
heart disease with hypertension being the main risk factor (n¼43, 55.8%). 49% (n¼38)
were considered independent in terms of ADLs. Patient mortality at 30 days post
STEMI was 55.8%. This increased to 61% at 1 year.
Conclusion: As the older demographic in our population increases, this patient cohort
will become particularly signiﬁcant. Mortality among these patients is high yet a sig-
niﬁcant number were considered independent in terms of ADLs. Prospective evalu-
ation of this patient cohort needs to take place to monitor the effect of the introduction
of the PPCI National Strategy in Ireland in 2012. Internationally, larger studies are
needed to determine the role of social factors as predictors of non-reperfusion.CRT-116
Predictors of Inappropriate Activation of the Cardiac Catheterization Laboratory for
Code STEMI
Tiffany Wang, Gaurav Sharma, Henry Chu, David M. Shavelle
University of Southern California, Los Angeles, CA
Background: Patients presenting with ST elevation myocardial infarction (STEMI)
beneﬁt from primary percutaneous coronary intervention (PCI) if performed in a
timely manner. Inappropriate activation (IA) of the cardiac catheterization laboratory
is associated with signiﬁcant time and ﬁnancial costs. Patient level predictors of IA
have not been well-characterized. The objective of this study was to determine pre-
dictors of IA in patients activated for code STEMI.
Methods: We retrospectively analyzed a cohort of 396 consecutive patients who were
activated for code STEMI from January 2009 through April 2011 at a large, urban
teaching hospital. Those who underwent emergent coronary angiography (with or without
PCI) were categorized as having appropriate activation (n¼228). Patients for whom code
STEMI activation was subsequently cancelled and did not undergo emergent coronary
angiography were categorized as inappropriate activation (n¼168). Both groups were
compared and predictors for IA were determined using multivariate logistic regression
analysis.
Results: IA occurred in 42% of patients activated for code STEMI. Mean age, gender
distribution, and history of prior myocardial infarction were similar between the
groups. Body mass index < 18.5, use of self-transport to the emergency department,
initial complaint, recent cocaine use, history of congestive heart failure, and history of
atrial ﬁbrillation were signiﬁcantly between the two groups. Independent predictors for
IA included age  35 years (odds ratio [OR], 4.85; 95% CI, 1.18-19.96; p¼0.03),
body mass index <18.5 (OR, 15.91; 95% CI, 5.38-47.07; p<0.0001), absence of both
chest pain and shortness of breath at presentation (OR, 3.21; 95% CI, 1.79-5.76;
p<0.0001), recent cocaine use (OR, 5.01; 95% CI, 1.19-10.12; p¼0.02), history of
congestive heart failure (OR, 3.59; 95% CI, 1.58-8.13; p¼0.002), and history of atrial
ﬁbrillation (OR, 3.47; 95% CI, 1.19-10.12; p¼0.02).
Conclusions: Multiple patient-level characteristics were associated with IA of the
cardiac catheterization laboratory. Younger age, absence of both chest pain and
shortness of breath, recent cocaine use, and history of heart failure and atrial ﬁbrillation
were independent predictors of IA.
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Hispanic Patients Undergoing Primary PCI within Los Angeles County STEMI Receiving
System
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Background:Hispanics are one of the largest growing ethnic minorities in the United
States but have been under represented in contemporary cardiovascular trials. Infor-
mation regarding Hispanic patients treated with Primary PCI within a regional
STEMI system of care has not been previously reported.
Methods: The Los Angeles County Emergency Medical System (EMS) STEMI
Receiving Center (SRC) Database was queried from January 2007 to December 2011
to identify all patients with a pre-hospital ECG showing STEMI. Eight thousand,
eight hundred and thirty-seven patients were included; 1,737 (19.7%) were Hispanic
and 4,637 (52.5%) were non-Hispanic whites. Hispanic and non-Hispanic whites
undergoing primary PCI were compared based upon demographics, treatment time
intervals and in-hospital clinical outcome.
Results: Hispanic patients were younger compared to non-Hispanic whites, 62.8 vs 67.5
years, p<0.0001, respectively. Treatment times including medical contact to door time (21
 12.9 vs 20.7 12.2mins, p¼ 0.43) and door to balloon time (63.1 31.7 vs 63.9 33.1
mins, p¼ 0.20) were similar between the Hispanic and non-Hispanic whites, respectively.
Hispanic patients achieved a higher rate of TIMI 3 ﬂow in the infarct related artery
compared to non-Hispanic whites, 86.7% vs 83.7%, p ¼ 0.04, respectively. The rate of
vascular complications, need for emergent coronary artery bypass surgery, occurrence of
stroke, length of hospital stay and in-hospital mortality were similar between the groups
(Table).
